<ARTICLE>                                  5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements included in the Form 10-QSB for the quarter ended February
28, 1999, of Endogen, Inc. to which this exhibit is a part and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                               1,000
       
                                        
<PERIOD-TYPE>                              9-MOS
<FISCAL-YEAR-END>                          MAY-31-1999
<PERIOD-START>                             JUN-01-1998
<PERIOD-END>                               FEB-28-1999
<CASH>                                                              864
<SECURITIES>                                                          0
<RECEIVABLES>                                                     1,415
<ALLOWANCES>                                                         50
<INVENTORY>                                                       2,141
<CURRENT-ASSETS>                                                  5,030
<PP&E>                                                            4,081
<DEPRECIATION>                                                    2,370
<TOTAL-ASSETS>                                                    7,563
<CURRENT-LIABILITIES>                                             1,440
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                             35
<OTHER-SE>                                                        6,003
<TOTAL-LIABILITY-AND-EQUITY>                                      7,563
<SALES>                                                           7,339
<TOTAL-REVENUES>                                                  7,469
<CGS>                                                             2,951
<TOTAL-COSTS>                                                     7,928
<OTHER-EXPENSES>                                                      0
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                    3
<INCOME-PRETAX>                                                    (462)
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                                (462)
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                       (462)
<EPS-PRIMARY>                                                      (.13)
<EPS-DILUTED>                                                      (.13)